Erradicación de Escherichia coli de la orina vesical por amoxicilina-sulbactam. Actividad intrínseca del inhibidor
- 1 January 2001
- journal article
- Published by Elsevier in Enfermedades Infecciosas y Microbiología Clínica
- Vol. 19 (5) , 206-210
- https://doi.org/10.1016/s0213-005x(01)72614-6
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- BACTERIAL RESISTANCE TO ANTIMICROBIAL AGENTS IN LATIN AMERICA: The Giant Is AwakeningInfectious Disease Clinics of North America, 2000
- A Pharmacodynamic Model to Support a 12-Hour Dosing Interval for Amoxicillin/Sulbactam, a Novel Oral Combination, in the Treatment of Community-Acquired Lower Respiratory Tract InfectionsJournal of Chemotherapy, 2000
- Pharmacokinetics and Pharmacodynamics of Amoxicillin-Sulbactam, a Novel Aminopenicillin–β-Lactamase Inhibitor Combination, against Escherichia coliAntimicrobial Agents and Chemotherapy, 1999
- Clavulanic acid and CP-45, 899: a comparison of their in vitro activity in combination with penicillinsJournal of Antimicrobial Chemotherapy, 1980